Methods for quantitative gait analysis in CLN3 disease

被引：0
|
作者：
Zimmerman, Grace [1 ]
Vierhile, Amy [1 ]
Adams, Heather [1 ]
Mink, Jonathan [1 ]
Augustine, Erika [1 ]
机构：
[1] Univ Rochester, Rochester, NY USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2020年 / 129卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2019.11.444
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
435
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 50 条
  • [31] Autophagic vacuolar myopathy is a common feature of CLN3 disease
    Radke, Josefine
    Koll, Randi
    Gill, Esther
    Wiese, Lars
    Schulz, Angela
    Kohlschuetter, Alfried
    Schuelke, Markus
    Hagel, Christian
    Stenzel, Werner
    Goebel, Hans H.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2018, 5 (11): : 1385 - 1393
  • [32] Novel morphological macular findings in juvenile CLN3 disease
    Dulz, S.
    Wagenfeld, L.
    Nickel, M.
    Richard, G.
    Schwartz, R.
    Bartsch, U.
    Kohlschuetter, A.
    Schulz, A.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2016, 100 (06) : 824 - 828
  • [33] Analysis of Potential Biomarkers and Modifier Genes Affecting the Clinical Course of CLN3 Disease
    Lebrun, Anne-Helene
    Moll-Khosrawi, Parisa
    Pohl, Sandra
    Makrypidi, Georgia
    Storch, Stephan
    Kilian, Dirk
    Streichert, Thomas
    Otto, Benjamin
    Mole, Sara E.
    Ullrich, Kurt
    Cotman, Susan
    Kohlschuetter, Alfried
    Braulke, Thomas
    Schulz, Angela
    MOLECULAR MEDICINE, 2011, 17 (11-12) : 1253 - 1261
  • [34] Parent-reported benefits of flupirtine in Juvenile Batten Disease (CLN3) are not supported by quantitative data
    Cialone, J.
    Augustine, E. F.
    Newhouse, N.
    Adams, H.
    Vierhile, A.
    Marshall, F. J.
    de Blieck, E. A.
    Kwon, J. M.
    Rothberg, P. G.
    Mink, J. W.
    ANNALS OF NEUROLOGY, 2011, 70 : S136 - S136
  • [35] Motor function impairment is an early sign of CLN3 disease
    Kuper, Willemijn F. E.
    van Alfen, Claudia
    van Eck, Linda
    Huijgen, Barbara C. H.
    Nieuwenhuis, Edward E. S.
    van Brussel, Marco
    van Hasselt, Peter M.
    NEUROLOGY, 2019, 93 (03) : E293 - E297
  • [36] Drug-induced hyperthermia with rhabdomyolysis in CLN3 disease
    Savvidou, A.
    Jennions, E.
    Wikstrom, S.
    Olsson-Engman, M.
    Sofou, K.
    Darin, N.
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2022, 39 : 74 - 78
  • [37] Membrane topology of CLN3, the protein underlying Batten disease
    Mao, QW
    Foster, BJ
    Xia, HB
    Davidson, BL
    FEBS LETTERS, 2003, 541 (1-3) : 40 - 46
  • [38] The UBDRS predicts rate of JCNL (CLN3) disease progression
    Mink, Jonathan
    Kwon, Jennifer M.
    Marshall, Frederick J.
    Adams, Heather R.
    Rothberg, Paul G.
    deBlieck, Elisabeth A.
    Vierhile, Amy
    Newhouse, Nicole J.
    Levy, Erika J.
    Augustine, Erika F.
    Ramirez-Montealegre, Denia
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (02) : S27 - S27
  • [39] Evidence for phosphorylation of CLN3 protein associated with Batten disease
    Michalewski, MP
    Kaczmarski, W
    Golabek, AA
    Kida, E
    Kaczmarski, A
    Wisniewski, KE
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 253 (02) : 458 - 462
  • [40] CLN3 in cancer, development, and senescence
    Guo, WX
    Chang, J
    Pane, M
    Boustany, RM
    ANNALS OF NEUROLOGY, 1998, 44 (03) : 546 - 546
12345